实时快讯
政策法规 现行有效欧盟(统一法规)危险品合规

Understanding Biocidal Products Regulation (BPR)

效力法规类型发布日期生效日期发文机构
现行有效规范性文件2012-05-222012-05-22European Chemicals Agency (ECHA)
发布05-22
生效05-22
摘要总结AI 辅助解读
欧盟《生物杀灭剂产品法规》(BPR, Regulation (EU) 528/2012)于2013年9月1日正式适用。该法规规范生物杀灭剂(如防虫、抗菌产品)的市场投放与使用,核心要求是:所有生物杀灭剂在上市前必须获得授权,且其活性物质需预先通过欧盟批准。法规旨在统一市场规则,简化审批流程,并引入强制数据共享以减少动物测试。申请主要通过R4BP 3和IUCLID平台进行。对于处于审查计划中的活性物质或新活性物质,存在特定的过渡期例外规定。
官方原文
外文原文 · 可AI翻译 · 可溯源

The Biocidal Products Regulation (BPR, Regulation (EU) 528/2012) concerns the placing on the market and use of biocidal products, which are used to protect humans, animals, materials or articles against harmful organisms like pests or bacteria, by the action of the active substances contained in the biocidal product. This regulation aims to improve the functioning of the biocidal products market in the EU, while ensuring a high level of protection for humans and the environment. The text was adopted on 22 May 2012 and is applicable since 1 September 2013. All biocidal products require an authorisation before they can be placed on the market, and the active substances contained in that biocidal product must be previously approved. There are, however, certain exceptions to this principle. For example, biocidal products containing active substances in the Review Programme can be made available on the market and used (subject to national laws) pending the final decision on the approval of the active substance (and up to 3 years after). Products containing new active substances that are still under assessment may also be allowed on the market where a provisional authorisation is granted. The BPR aims to harmonise the market at Union level; simplify the approval of active substances and authorisation of biocidal products; and introduce timelines for Member State evaluations, opinion-forming and decision-making. It also promotes the reduction of animal testing by introducing mandatory data sharing obligations and encouraging the use of alternative testing methods. The approval of active substances takes place at Union level and the subsequent authorisation of the biocidal products at Member State level. This authorisation can be extended to other Member States by mutual recognition. The regulation provides applicants with the possibility of an authorisation at Union level (Union authorisation). A dedicated IT platform, the Register for Biocidal Products (R4BP 3), is used for submitting applications, exchanging data and information between the applicant, ECHA, Member State competent authorities and the European Commission. Another IT tool, IUCLID, is used for preparing the applications.

§
免责声明:以上内容通过公开渠道搜集整理,仅供业界参考与内部交流使用,不构成任何形式的商业决策指导或法律建议;实际执行标准请以官方机构发布的最新原文及主管部门解释为准。 摘要、条款解读与影响分析内容由 AI 辅助生成,仅供参考,不构成法律意见;原文更新后解读将同步重新生成。